STOCKHOLDERS' EQUITY [Text Block] | 6. STOCKHOLDERS' EQUITY [a] Common stock issued and authorized The Company is authorized to issue up to 20,000,000 shares of common stock, par value $0.001 per share. During the three and nine months ended May 31, 2024, the Company did not issue any common stock (May 31, 2023 - Nil and Nil, respectively). During the three and nine months ended May 31, 2024, the Company repurchased and cancelled 149,900 and 459,200 common shares for $163,591 and $470,271 respectively (during the three and nine months ended May 31, 2023 - repurchased and cancelled 5,685 common shares for $4,463). [b] Stock option plans Pursuant to the Company's 2015 Stock Option Plan (the "2015 Plan"), 530,000 shares of common stock have been reserved for issuance. A total of 420,000 common shares remain eligible for issuance under the 2015 Plan. On February 18, 2022 the Company received shareholder approval for the 2022 Stock Option Plan (the "2022 Plan") (together with the 2015 Plan, the "Plans"), whereby 1,000,000 common shares are reserved for issuance. As of May 31, 2024, 367,000 common shares remain eligible for issuance under the 2022 Plan. The options generally vest over a range of periods from the date of grant, some are immediate, and others vest over 24 months. Any options that do not vest as the result of a grantee leaving the Company are forfeited and the underlying common shares are returned to the reserve. The options generally have a contractual term of five years. Stock-Based Payment Award Activity A summary of stock option activity under the Plans as of May 31, 2024, and changes during the period were the following: Number of Options Weighted Average Exercise Price Weighted Average Aggregate Intrinsic Value Outstanding at August 31, 2022 593,000 $ 1.49 3.79 $ - Granted 228,000 $ 0.85 4.90 $ - Forfeited (72,000 ) $ 1.41 3.41 $ - Outstanding at August 31, 2023 749,000 $ 1.30 3.37 $ - Granted 20,000 $ 1.15 4.86 $ - Forfeited (23,416 ) $ 1.13 3.39 $ 658 Expired (2,584 ) $ 1.29 2.98 $ 42 Outstanding at May 31, 2024 743,000 $ 1.31 2.66 $ 10,200 Exercisable at May 31, 2024 608,807 $ 1.39 2.31 $ 4,511 During the three and nine months ended May 31, 2024, the Company granted 20,000 stock options to the employees of the Company (three and nine months ended May 31, 2023 - Nil). The weighted-average assumptions used to estimate the fair value of stock options using the Black-Scholes option valuation model were as follows: risk-free interest rate - 4.37%, volatility - 85.31%, exercise price - $1.15, dividend yield - 0%, forfeiture rate - 0%, expected life - 2.13 years. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company's common stock for the options that were in-the-money as of May 31, 2024. As of May 31, 2024, the aggregate intrinsic value of outstanding and exercisable options was $10,200 and $4,511, respectively (May 31, 2023 - $Nil and $Nil, respectively). As of May 31, 2024, there was $59,082 (May 31, 2023 - $72,153) of total unrecognized compensation cost related to non-vested stock-based compensation awards. The unrecognized compensation cost is expected to be recognized over a weighted average period of 0.77 years (May 31, 2023 - 1.5 years). During the three and nine months ended May 31, 2024, the Company recorded $11,359 and $35,819 in non-cash stock-based compensation, respectively (May 31, 2023 - $38,085 and $113,327, respectively). [c] Employee Stock Purchase Plan The Company's 2011 Employee Stock Purchase Plan (the "ESPP") became effective on February 22, 2011. Under the ESPP, employees of the Company can contribute up to 5% of their annual salary into a pool which is matched equally by the Company in order to purchase the Company's common shares under certain terms. Directors can contribute a maximum of $12,500 each for a combined maximum annual purchase of $25,000. The maximum annual combined contributions will be $400,000. All purchases are made through TSXV by a third-party plan agent. The third-party plan agent is also responsible for the administration of the ESPP on behalf of the Company and the participants. During the three and nine months ended May 31, 2024, the Company recognized compensation expense of $17,734 and $51,664, respectively (May 31, 2023 - $47,878 and $87,100, respectively) in salaries and wages on the condensed consolidated statement of comprehensive income (loss) in respect of the ESPP, representing the Company's employee matching of cash contributions to the ESPP. The shares were purchased on the open market at an average price of $1.02 over a nine-month period (May 31, 2023 - $1.09). The shares are held in trust by the Company for a period of one year from the date of purchase. As of May 31, 2024, 139,293 shares were held in trust by the Company. [d] Earnings Per Share Net income (loss) per common share (basic) is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Net income (loss) per common share (diluted) is calculated by dividing net income (loss) for the period by the weighted average number of common shares outstanding during the period, plus the dilutive effect of outstanding common share equivalents. This method requires that the dilutive effect of outstanding options and warrants issued be calculated using the treasury stock method. Under the treasury stock method, all common share equivalents have been exercised at the beginning of the period (or at the time of issuance, if later), and that the funds obtained thereby were used to purchase common shares of the Company at the average trading price of common shares during the period, but only if dilutive. The following table shows the computation of basic and diluted earnings per share for the three and nine months ended May 31, 2024, and 2023: Three Months Ended May 31, Nine Months Ended May 31, 2024 2023 2024 2023 Numerator: Net income $ 134,476 $ 107,052 $ 253,980 $ 364,042 Denominator: Weighted-average basic shares outstanding 9,689,303 10,123,984 9,846,942 10,124,168 Effect of dilutive stock-based awards 32,732 - 41,499 - Weighted-average diluted shares 9,722,035 10,123,984 9,888,441 10,124,168 Basic and diluted earnings per share $ 0.01 $ 0.01 $ 0.03 $ 0.04 479,000 stock options were excluded from the computation of diluted earnings per share for the three and nine months ended May 31, 2024, because their effect would have been antidilutive. |